Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Financial Flexibility Index
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-14.87 Million (operating CF $-28.73 Million minus capex $13.86 Million) represents 0% of total liabilities ($3.59 Billion). Check Amneal Pharmaceuticals, Inc. Class A Com PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Amneal Pharmaceuticals, Inc. Class A Common Stock Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Amneal Pharmaceuticals, Inc. Class A Common Stock across 11 annual periods. See Amneal Pharmaceuticals, Inc. Class A Com short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Amneal Pharmaceuticals, Inc. Class A Common Stock (2015–2025)
Year-by-year free cash flow to debt coverage for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full company profile including market capitalisation, see Amneal Pharmaceuticals, Inc. Class A Com (AMRX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | $410.06 Million | $339.99 Million | $3.67 Billion | ▲ +7.0% |
| 2024 | 0.10x | $370.09 Million | $295.10 Million | $3.55 Billion | ▼ -14.2% |
| 2023 | 0.12x | $414.77 Million | $345.58 Million | $3.41 Billion | ▲ +180.4% |
| 2022 | 0.04x | $155.69 Million | $65.10 Million | $3.59 Billion | ▼ -46.5% |
| 2021 | 0.08x | $289.55 Million | $241.82 Million | $3.57 Billion | ▼ -32.9% |
| 2020 | 0.12x | $440.84 Million | $379.00 Million | $3.65 Billion | ▲ +304.4% |
| 2019 | 0.03x | $99.14 Million | $1.71 Million | $3.32 Billion | ▼ -70.3% |
| 2018 | 0.10x | $347.32 Million | $250.23 Million | $3.46 Billion | ▼ -50.5% |
| 2017 | 0.20x | $348.46 Million | $234.19 Million | $1.72 Billion | ▲ +18.1% |
| 2016 | 0.17x | $239.67 Million | $115.06 Million | $1.39 Billion | ▼ -7.2% |
| 2015 | 0.19x | $222.26 Million | $104.88 Million | $1.20 Billion | — |